Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - CAPITAL EXPENDITURES
Capital Expenditures PTGX - Protagonist Therapeutics, Inc.
-609 K
LAST VALUE
25.63%
2 YEAR CAGR
-4.62%
5 YEAR CAGR
0.00%
10 YEAR CAGR